Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Progyny stock in Canada | $61.93

Own Progyny shares in just a few minutes.

Progyny, Inc

Progyny (PGNY) is a leading health information services business based in the US. It opened the day at $59.85 after a previous close of $59.55. During the day the price has varied from a low of $59.25 to a high of $61.96. The latest price was $61.93 (25 minute delay). Progyny is listed on the NASDAQ and employs 210 staff. All prices are listed in US Dollars.

How to buy Progyny stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: PGNY in this case.
  5. Research Progyny stocks. The platform should provide the latest information available.
  6. Buy your Progyny stocks. It's that simple.

How has Coronavirus impacted Progyny's stock price?

Since the stock market crash in March caused by coronavirus, Progyny's stock price has had significant positive movement.

Its last market close was $64.04, which is 53.17% up on its pre-crash value of $29.99 and 310.78% up on the lowest point reached during the March crash when the stocks fell as low as $15.59.

If you had bought $1,000 worth of Progyny stocks at the start of February 2020, those stocks would have been worth $617.95 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,402.78.

Progyny stock price

Use our graph to track the performance of PGNY stocks over time.

Progyny stocks at a glance

Information last updated 2021-06-28.
Previous close$59.55
Change $2.38
Change % 3.9966%
Volume 1,071,076
Information last updated 2021-07-23.
52-week range$23.56 - $66.61
50-day moving average $60.685
200-day moving average $52.1772
Wall St. target price$66.33
PE ratio 96.5749
Dividend yield N/A (0%)
Earnings per share (TTM) $0.581

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are greater than or equal to US$10.00)
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Trade 100 select ETFs free of charge.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Progyny stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Progyny price performance over time

Historical closes compared with the last close of $61.93

1 month (2021-06-25) 4.00%
3 months (2021-04-26) 10.79%

Is Progyny under- or over-valued?

Valuing Progyny stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Progyny's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Progyny's P/E ratio

Progyny's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 97x. In other words, Progyny stocks trade at around 97x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stocks or simply that they're over-valued.

Progyny's EBITDA

Progyny's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$27.9 million.

The EBITDA is a measure of a Progyny's overall financial performance and is widely used to measure a its profitability.

Progyny financials

Revenue TTM USD$386 million
Operating margin TTM 6.75%
Gross profit TTM USD$70.1 million
Return on assets TTM 6.86%
Return on equity TTM 37.94%
Profit margin 15.03%
Book value $2.104
Market capitalisation USD$5 billion

TTM: trailing 12 months

How to short and sell Progyny stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "PGNY.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 4.0 million Progyny stocks held short by investors – that's known as Progyny's "short interest". This figure is 47.9% up from 2.7 million last month.

There are a few different ways that this level of interest in shorting Progyny stocks can be evaluated.

Progyny's "short interest ratio" (SIR)

Progyny's "short interest ratio" (SIR) is the quantity of Progyny stocks currently shorted divided by the average quantity of Progyny stocks traded daily (recently around 1.3 million). Progyny's SIR currently stands at 3.02. In other words for every 100,000 Progyny stocks traded daily on the market, roughly 3020 stocks are currently held short.

However Progyny's short interest can also be evaluated against the total number of Progyny stocks, or, against the total number of tradable Progyny stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Progyny's short interest could be expressed as 0.05% of the outstanding stocks (for every 100,000 Progyny stocks in existence, roughly 50 stocks are currently held short) or 0.0596% of the tradable stocks (for every 100,000 tradable Progyny stocks, roughly 60 stocks are currently held short).

Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Progyny.

Find out more about how you can short Progyny stock.

Progyny stock dividends

We're not expecting Progyny to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Progyny overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site